Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study.

Adam C Livori MClinPharmDerk PolBianca LevkovichErnesto Oqueli

Published in: International journal of clinical pharmacy (2023)

This novel intervention significantly improved adherence to secondary prevention medications at 12 months, a demonstrated contributor to clinical outcomes. Primary and secondary outcomes in the intervention group were both statistically significant. Pharmacist-led follow up improves adherence and patient outcomes.

Keyphrases

acute coronary syndrome
randomized controlled trial
glycemic control
primary care
percutaneous coronary intervention
type diabetes
antiplatelet therapy
metabolic syndrome
adipose tissue
skeletal muscle
insulin resistance
atrial fibrillation